Details of the large-scale private sector participation in the COVID-19 vaccination campaign will be available in “a few days,” NITI Aayog member Dr VK Paul, who is leading the case response team, told The Bharat Express News. pandemic center.
To date, more than 1.07 million doses of the vaccine have been administered to healthcare professionals and frontline medical workers.
“Also now, the private sector has been heavily involved in immunizing health and frontline workers. Out of 10,000 immunization sessions every day, 2,000 are conducted by private sector partners, ”said Dr Paul. “And as we move to a much faster agenda, the private sector engagement will get deeper and deeper. In a few days just wait a bit,” he said.
Large-scale private sector participation in the COVID-19 vaccination campaign will be necessary as more sections of the population become eligible for the bites. For now, only frontline health and medical personnel are vaccinated. But even then, some of them fear that they will not get the vaccine, although the center repeatedly says the vaccines are safe.
The Confederation of Indian Industry (CII) recently asked the center to authorize broader private sector participation in the vaccination campaign. “Hospitals [should] be authorized to vaccinate critical patients and paying clients, eventually, to ensure that the vaccine reaches all as soon as possible, without diverting resources from the government strategy of beneficiaries, ”said the head of the CII, Uday Kotak, in a letter to Prime Minister Narendra Modi last month.
On the Russian-made Sputnik vaccine, Dr Paul said he was “very happy that Sputnik requested emergency use in India.”
The Sputnik vaccine, peer-reviewed by the Lancet Medical Journal, is being tested in India and Dr Reddy’s labs are in the process of making the vaccine. Currently, two vaccines – Covishield from the Serum Institute of India and Covaxin from Bharat Biotech – are being administered to healthcare and frontline workers.
“Dr Reddy’s labs have applied for clearance on behalf of Sputnik. This process will take place in the next few days… We are undertaking this process very quickly because we want as many vaccine options as possible, ”said Dr Paul.
The Sputnik trial was conducted on 36,000 people, including 33,000 of Russian nationality. In addition, transition studies are underway in India and the United Arab Emirates. In India, the trials are carried out on 1,600 people.
COVID-19 cases have increased in recent days in some states such as Maharashtra and Punjab. At least 240 new strains of the coronavirus have surfaced across India, which are behind the new wave of infections seen since last week, said Dr Shahshank Joshi, a member of the COVID-19 task force. from Maharashtra, to The Bharat Express News.